IGFN1

IGFN1 is a skeletal muscle Z-band/Z-disc-associated protein that scaffolds the contractile apparatus and governs myoblast fusion and differentiation through control of actin dynamics (PMID:20206623, PMID:28665998, PMID:32768501). Its three N-terminal globular domains are sufficient for Z-band targeting, where it assembles into a complex with KY and filamin C (FLNC) (PMID:20206623). Loss of all IGFN1 variants by shRNA, or deletion of exon 13 encoding N-terminal domains, completely blocks myoblast fusion and produces abnormal large multinucleated cells without preventing differentiation-marker expression, and re-expression of IGFN1_v1 partially rescues these defects (PMID:28665998). Mechanistically, IGFN1-deficient myoblasts show elevated G:F actin ratios indicative of deficient actin remodelling; IGFN1 binds, stabilizes, and co-localizes at the Z-disc with the actin-nucleating protein COBL and restrains COBL-driven actin ruffling (PMID:32768501). IGFN1 also binds eukaryotic translation elongation factor eEF1A and is strongly upregulated during muscle denervation, linking it to protein-synthesis regulation in muscle (PMID:18756455). At the gene level, a stable G-quadruplex in intron 15 modulates alternative splicing of the locus (PMID:30335789).

1. 2008 Medium

   Established a first molecular partner and regulatory context for IGFN1 by identifying it as an eEF1A-binding muscle protein induced during denervation, hinting at a role coupling muscle state to translational machinery.

   Evidence Yeast two-hybrid screening of a human skeletal muscle cDNA library with in vitro binding confirmation

   PMID:18756455

   Open questions at the time

   • Functional consequence of the eEF1A interaction on translation not demonstrated
   • Denervation upregulation correlative, not mechanistically tied to eEF1A binding
   • No structural mapping of the interaction interface
2. 2010 Medium

   Placed IGFN1 at the Z-band as part of a defined sarcomeric complex, defining where in muscle architecture it operates.

   Evidence Yeast two-hybrid, recombinant domain mapping, and immunofluorescence in C2C12 myotubes and neonatal cardiomyocytes

   PMID:20206623

   Open questions at the time

   • Functional role of the IGFN1/KY/FLNC complex not tested
   • Single-lab interaction data without in vivo validation
   • Stoichiometry and assembly order of the complex unknown
3. 2017 High

   Demonstrated that IGFN1 is functionally required for myoblast fusion, moving it from a structural component to a determinant of muscle cell morphogenesis.

   Evidence shRNA knockdown and CRISPR/Cas9 exon 13 deletion with IGFN1_v1 rescue in C2C12 cells

   PMID:28665998

   Open questions at the time

   • Molecular mechanism downstream of IGFN1 not resolved in this study
   • Only partial rescue achieved
   • In vivo muscle phenotype not addressed
4. 2020 High

   Identified the mechanistic basis of the fusion defect as deficient actin remodelling and linked IGFN1 to the actin nucleator COBL, explaining how a Z-disc scaffold controls cytoskeletal dynamics.

   Evidence G:F actin assays, IGFN1 fragment pull-down proteomics, co-IP/co-localization, actin ruffle assay in COS7, and COBL loss-of-function clones

   PMID:32768501

   Open questions at the time

   • COBL loss-of-function clones still fuse, so COBL is not essential for fusion
   • The fusion-relevant actin effector downstream of IGFN1 remains unidentified
   • Role of the proteasome network found in IGFN1 complexes not defined
5. 2018 Medium

   Showed that gene-level regulation of IGFN1 isoforms is controlled by an intronic G-quadruplex, adding a transcript-processing layer to its biology.

   Evidence Gel shift, circular dichroism, polymerase stop assays, and pyridostatin-induced splicing changes in UOK146 cells

   PMID:30335789

   Open questions at the time

   • Splicing effect shown in a renal carcinoma line, not skeletal muscle
   • Endogenous splicing factors reading the G-quadruplex not identified
   • Physiological relevance of isoform switching not established

• The effector pathway by which IGFN1-dependent actin remodelling drives myoblast fusion, and how its Z-disc, eEF1A, and splicing functions integrate in vivo, remain unresolved.
• No in vivo (animal) loss-of-function phenotype in the corpus
• Fusion-essential actin effector unidentified
• Functional consequence of eEF1A binding undefined